Clinical Trials Industry News More

41. Exploring Powder Dispersion For Inhaled Drug Applications
    11/11/2009
    Dr Paul Kippax, product manager for diffraction systems at Malvern Instruments, is one of a group of powder dispersion and characterization experts who will speak in Leeds, UK, on 8 December 2009 at a meeting on ‘Dispersion and Characterization of Dry Cohesive Powders for Inhalation and Particle Sizing’.
42. Human Genome Sciences And Glaxosmithkline Announce Positive Results In Second Of Two Phase 3 Trials Of Benlysta™ In Systemic Lupus Erythematosus
    11/5/2009
    Human Genome Sciences, Inc. and GlaxoSmithKline PLC (GSK) recently announced that BENLYSTA (belimumab) met the primary endpoint in BLISS-76, the second of two pivotal Phase 3 trials in seropositive patients with systemic lupus erythematosus (SLE).
43. Malvern Sponsors Protein Aggregation Track At PepTalk 2010
    11/5/2009
    As well as presenting a technical paper and exhibiting from its range of Zetasizer light scattering solutions and Viscotek size exclusion chromatography systems, Malvern Instruments is sponsoring the ‘Protein Aggregation’ track at the next Cambridge Healthtech Institute PepTalk conference (January 11-15, 2010, San Diego, California).
44. World’s largest Malaria Vaccine Trial Now Underway In Seven African Countries
    11/5/2009
    A pivotal efficacy trial of RTS,S, the world’s most clinically advanced malaria vaccine candidate, is now underway in seven African countries: Burkina Faso, Gabon, Ghana, Kenya, Malawi, Mozambique and Tanzania.
45. Malvern Instruments And Kaiser Optical Systems Collaborate To Develop An Advanced Range Of Raman Microscopes
    10/29/2009
    Materials characterization company Malvern Instruments (Malvern, Worcs, UK) and Kaiser Optical Systems (Ann Arbor, MI, USA), a leading supplier of Raman analyzers and components for spectroscopy, announce a development collaboration that will enhance the product portfolios of both companies.
46. Millipore Scientist To Lead PDA Web Seminar On Innovative Testing Methods For Detecting Mycoplasma Contamination
    10/28/2009
    Millipore Corporation, a leading provider of technologies, tools and services for the global life science industry, will lead a web-based seminar on detection of Mycoplasma and viral contamination, a subject of heightened interest in biopharmaceutical manufacturing.
47. Icagen Reports Top-Line Results Of Phase IIa Study Of Senicapoc In Exercise-Induced Asthma
    10/28/2009
    Icagen, Inc. today reported that in a proof-of-concept, Phase IIa exercise-induced asthma study, senicapoc failed to demonstrate improvement in the primary study endpoints, including maximum decrease in FEV1, time to recovery of FEV1 after exercise and area under the FEV1 curve for sixty minutes.
48. TransMolecular’s ¹³¹I-Tm601 Shown To Improve Survival In Recurrent Malignant Glioma
    10/26/2009

    TransMolecular, Inc., a developer of innovative oncology drugs through targeted delivery technologies, recently announced final results from its Phase 2 clinical study comparing the toxicity and overall survival of three versus six intracavitary injections of its anti-cancer compound ¹³¹I-TM601 in the treatment of recurrent malignant glioma.

49. Malvern Instruments Welcomes New OPC Specification For Analyzer Device Integration
    10/26/2009
    The release of the first OPC analyzer device integration (ADI) specification has been welcomed by Malvern Instruments, one of the founder members of the working group set up in 2008 to develop a common method for data exchange and an analyzer model for process and laboratory systems.
50. Surface Dissolution Imaging Gives Insight Into Bioavailability
    10/21/2009
    Paraytec has announced that it will be demonstrating an exciting new tool for surface dissolution imaging - the ActiPix SDI300 at the 2009 American Association for Pharmaceutical Scientists (AAPS) meeting in Los Angeles, CA.